BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37563718)

  • 1. Can the ultrasound microcystic pattern accurately predict borderline ovarian tumors?
    Liu D; Lyu G; Lai H; Li L; Gan Y; Yang S
    J Ovarian Res; 2023 Aug; 16(1):162. PubMed ID: 37563718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components.
    Timor-Tritsch IE; Foley CE; Brandon C; Yoon E; Ciaffarrano J; Monteagudo A; Mittal K; Boyd L
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):395-402. PubMed ID: 30950132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcystic pattern and shadowing are independent predictors of ovarian borderline tumors and cystadenofibromas in ultrasound.
    Zheng X; Lyu G; Gan Y; Hu M; Liu X; Chen S; Wu X; Yang W; Ye F; Yan X; Zhang Y
    Eur Radiol; 2021 Jan; 31(1):45-54. PubMed ID: 32780208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
    Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Otify M; Laios A; Elshamy T; D'Angelo A; Amso NN
    Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():120-127. PubMed ID: 31785468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative sonographic features of borderline ovarian tumors.
    Exacoustos C; Romanini ME; Rinaldo D; Amoroso C; Szabolcs B; Zupi E; Arduini D
    Ultrasound Obstet Gynecol; 2005 Jan; 25(1):50-9. PubMed ID: 15619309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
    Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian masses with papillary projections diagnosed and removed during pregnancy: ultrasound features and histological diagnosis.
    Mascilini F; Savelli L; Scifo MC; Exacoustos C; Timor-Tritsch IE; De Blasis I; Moruzzi MC; Pasciuto T; Scambia G; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):116-123. PubMed ID: 27484484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors.
    Moro F; Zannoni GF; Arciuolo D; Pasciuto T; Amoroso S; Mascilini F; Mainenti S; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):261-270. PubMed ID: 28782867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
    Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
    J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors.
    Franchi D; Boveri S; Fruscio R; Fischerova D; Guerriero S; Moruzzi MC; Colombo N; Timmerman D; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):452-8. PubMed ID: 22858859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of ultrasound subjective 'pattern recognition' for the diagnosis of borderline ovarian tumors.
    Yazbek J; Raju KS; Ben-Nagi J; Holland T; Hillaby K; Jurkovic D
    Ultrasound Obstet Gynecol; 2007 May; 29(5):489-95. PubMed ID: 17444554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer arising in endometrioid cysts: ultrasound findings.
    Testa AC; Timmerman D; Van Holsbeke C; Zannoni GF; Fransis S; Moerman P; Vellone V; Mascilini F; Licameli A; Ludovisi M; Di Legge A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):99-106. PubMed ID: 21351179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of peri- and postmenopausal ovarian cysts.
    Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
    Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
    Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
    Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
    Lee EJ; Kim SH; Kim YH; Lee HJ
    Acta Radiol; 2011 May; 52(4):458-62. PubMed ID: 21498310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors.
    Pascual A; Guerriero S; Rams N; Juez L; Ajossa S; Graupera B; Hereter L; Cappai A; Pero M; Perniciano M; Errasti T; Parra J; Solis M; Alcázar JL
    Eur J Gynaecol Oncol; 2017; 38(3):382-386. PubMed ID: 29693878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
    Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.